Related Experiment Video
Updated: May 28, 2026
11:11
Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
Published on: December 17, 2016
Adeno-associated virus vector delivery to the heart
Lawrence T Bish1, H Lee Sweeney, Oliver J Müller
1Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|October 29, 2011
Summary
Optimized adeno-associated virus (AAV) gene transfer methods improve cardiac gene delivery in mice and rats. These new protocols enable efficient preclinical research for novel heart disease therapies.
Area of Science:
- Cardiovascular Research
- Gene Therapy
- Molecular Medicine
Background:
- Cardiac gene transfer is a promising therapeutic strategy for heart disease.
- Efficient gene transfer methods are crucial for preclinical research and development.
Purpose of the Study:
- To optimize Adeno-Associated Virus (AAV)-mediated cardiac gene transfer protocols in preclinical models.
- To establish safe and efficient methods for cardiac gene delivery in mice and rats.
Main Methods:
- Developed intrapericardial vector delivery in neonatal mice.
- Applied intravenous AAV injections in adult mice.
- Established direct myocardial injection and ultrasound-targeted microbubble destruction for AAV delivery in adult rats.
Main Results:
- Achieved efficient cardiac gene transfer in both mouse and rat models.
- Demonstrated the versatility of AAV vectors for cardiac applications.
- Validated novel delivery techniques for targeted gene delivery to the heart.
Conclusions:
- Optimized AAV protocols provide reliable methods for cardiac gene transfer.
- These advancements facilitate robust preclinical evaluation of gene-based heart disease treatments.
- The developed techniques support the progression of cardiac gene therapy research.
